The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Modified FOLFOXIRI (mFOLFOXIRI) plus cetuximab (cet), followed by cet or bevacizumab (bev) maintenance, in RAS/BRAF wild-type (wt) metastatic colorectal cancer (mCRC): Results of the phase II randomized MACBETH trial by GONO.
 
Carlotta Antoniotti
No Relationships to Disclose
 
Chiara Cremolini
Consulting or Advisory Role - Amgen; Bayer; Merck Serono; Roche
Speakers' Bureau - Bayer
 
Fotios Loupakis
Consulting or Advisory Role - Amgen; Sanofi
Speakers' Bureau - Bayer; Roche; Sanofi
Research Funding - Merck Serono; Roche
 
Francesca Bergamo
No Relationships to Disclose
 
Roberta Grande
No Relationships to Disclose
 
Giuseppe Tonini
Consulting or Advisory Role - Amgen; Italfarmaco; Roche; Sanofi
 
Silvio Ken Garattini
No Relationships to Disclose
 
Gianluca Masi
Speakers' Bureau - Amgen; Bayer; Merck Serono; Roche
 
Francesca Battaglin
No Relationships to Disclose
 
Sara Lucchesi
No Relationships to Disclose
 
Lisa Salvatore
No Relationships to Disclose
 
Domenico C. Corsi
No Relationships to Disclose
 
Francesca Di Fabio
No Relationships to Disclose
 
Maria Banzi
No Relationships to Disclose
 
Elisa Sensi
No Relationships to Disclose
 
Daniela Tomcikova
No Relationships to Disclose
 
Gabriella Fontanini
No Relationships to Disclose
 
Vittorina Zagonel
Consulting or Advisory Role - Bayer; Roche
Speakers' Bureau - Amgen; Bayer; Merck Serono; Roche; Sanofi
 
Luca Boni
Research Funding - AMGEN (Inst)
Patents, Royalties, Other Intellectual Property - International Patent nr. PCT/EP2012/065661
 
Alfredo Falcone
Consulting or Advisory Role - Amgen; Bayer; Merck Serono; Roche; Sanofi
Speakers' Bureau - Amgen; Bayer; Merck Serono; Roche; Sanofi
Research Funding - Amgen; Merck Serono; Roche